MOLECULAR HEALTH DATAOME
LIVE

Serial Number

87048086

Owner

Molecular Health GmbH

Attorney

Peter T. Wakiyama

First Use Date

Nov 1, 2019

Filing Date

May 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MOLECULAR HEALTH DATAOME Trademark

Serial Number: 87048086 • Registration: 6158362

MOLECULAR HEALTH DATAOME is a trademark filed by Molecular Health GmbH on May 24, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Molecular Health GmbH (44 trademarks)

Belfortstr. 2
Heidelberg 69115 , DE

Entity Type: 03

Trademark Details

Filing Date

May 24, 2016

Registration Date

September 22, 2020

First Use Anywhere

November 1, 2019

First Use in Commerce

November 1, 2019

Published for Opposition

June 6, 2017

Goods & Services

Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devices, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans

Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to searchable online databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes

Financial administration of programs and services for payment and reimbursement of employee benefits in the nature of medical and health care diagnostic and treatment support programs, for employees and their family members and domestic partners

Business consulting and research services for employers in the field of employee benefits in the nature of offering medical and health care plans to employees and their family members and domestic partners for medical and health care diagnostic and treatment support programs

Medical consulting in the fields of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies; medical consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols

Scientific consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; Scientific consulting and research services in the nature of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing, and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, medical health information patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; Designing and developing searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; Providing a web site featuring non-downloadable software and algorithms for use by physicians, clinicians and other health care professionals, laboratory personnel, consultants, scientists and other researchers for conducting scientific, medical and pharmaceutical research; Providing a web site featuring software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; providing online, non-downloadable mobile and web applications for mobile devices, namely, smart phones and tablets, for accessing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; research services in the fields of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing a web site featuring online non-downloadable computer software and algorithms for medical diagnostic and treatment purposes; providing a web site featuring online non-downloadable software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing a web site featuring online non-downloadable mobile applications for mobile devices, namely, smart phones and tablets, and non-downloadable web applications accessible through the Internet, all for retrieval of information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 22, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 18, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 15, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 3, 2020 SUPC
USE AMENDMENT FILED
Jul 31, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 31, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2020 EXRA
SOU EXTENSION 5 GRANTED
Feb 6, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 6, 2020 AITU
SOU EXTENSION 5 FILED
Feb 3, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 3, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jul 29, 2019 EX4G
SOU EXTENSION 4 FILED
Jul 29, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 29, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2019 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2019 TCCA
SOU EXTENSION 3 GRANTED
Jan 30, 2019 EX3G
SOU EXTENSION 3 FILED
Jan 30, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 30, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 3, 2018 EXRA
SOU EXTENSION 2 GRANTED
Aug 1, 2018 EX2G
SOU EXTENSION 2 FILED
Aug 1, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 1, 2018 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2018 TCCA
ASSIGNED TO EXAMINER
Jul 9, 2018 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jan 31, 2018 EX1G
SOU EXTENSION 1 FILED
Jan 31, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 31, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 4, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 24, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 24, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2017 CRFA
ASSIGNED TO LIE
Mar 30, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 15, 2016 GPRN
PRIORITY ACTION E-MAILED
Sep 15, 2016 GPRA
PRIORITY ACTION WRITTEN
Sep 15, 2016 CPRA
ASSIGNED TO EXAMINER
Sep 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2016 NWOS
NEW APPLICATION ENTERED
May 27, 2016 NWAP